Milbank and Davis Polk & Wardwell advise Roche on its acquisition of LumiraDx’s Point of Care technology platform business via English pre-pack administration.
Roche acted as the acquirer in this Acquisition transaction.
The acquisition targeted assets operating in the Healthcare sector.
The transaction was announced on 30 Jul 2024 with a reported value of 3500000000.0.
Generated by AI, original source from - Data is in progress
LumiraDx group advisor
Firm name is in progress
Found it useful? Spread the word.
Milbank and Davis Polk & Wardwell advise Roche on its acquisition of LumiraDx’s Point of Care technology platform business via English pre-pack administration. | The Sponsor - The Sponsor
